MedPath
HSA Approval

EDISTRIDE FILM-COATED TABLET 10MG

SIN17048P

EDISTRIDE FILM-COATED TABLET 10MG

EDISTRIDE FILM-COATED TABLET 10MG

July 22, 2024

ASTRAZENECA SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantASTRAZENECA SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A10BK01

Manufacturer Information

ASTRAZENECA SINGAPORE PTE LTD

AstraZeneca Pharmaceuticals LP

Active Ingredients

Dapagliflozin Propanediol eqv to Dapagliflozin

10mg

Dapagliflozin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EDISTRIDE FILM-COATED TABLET 10MG - HSA Approval | MedPath